Treatment of Severe Myasthenia Gravis with Protein A Immunoadsorption and Cyclophosphamide
Peter Flachenecker(Neurologisches Rehabilitationszentrum Quellenhof Bad Wildbad), Klaus V. Toyka(Johns Hopkins University), D Wiebecke(University of Würzburg), Ralf Gold(St. Josef-Hospital), Behrouz Mansouri Taleghani(University of Bern), R. Großmann(University of Würzburg)
Cited by 22
Related Papers
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
|Brain|2011|1.2k
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
|Immunity|2015|919
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
|Cell|2020|627
PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS
|DIAL (Catholic University of Leuven)|2001|472